This company has been marked as potentially delisted and may not be actively trading. FibroGen (FGEN) Earnings Date, Estimates & Call Transcripts Add Compare Share Share Earnings Stock AnalysisAnalyst ForecastsEarningsFDA EventsHeadlinesInsider TradesOwnershipShort InterestTrendsBuy This Stock FibroGen Earnings Summary FibroGen posted Q3 2025 earnings on November 10, 2025, reporting an EPS of -$1.61, which topped the consensus estimate of -$4.01 by $2.40. Quarterly revenue was reported to be $1.08 million, below analysts' expectations of $1.64 million. With a trailing EPS of $53.48 and a P/E Ratio of 0.18, FibroGen's earnings are expected to grow next year, from ($0.80) to ($0.45) per share. Latest Q3 Earnings DateNov. 10EstimatedConsensus EPS (Nov. 10) -$4.01 Actual EPS (Nov. 10) -$1.61 Beat By $2.40 Actual Revenue (Nov. 10) $1.08MQ3 2025 Earnings ResourcesQ3 2025 Earnings ReportConference Call Transcript & Audio Slide Deck Press Release (8-K) Quarterly Report (10-Q)Slide DeckFull Screen Slide DeckPowered by Get FibroGen Earnings Alerts Want to stay updated on the latest earnings announcements and upcoming reports? Sign up for Earnings360's daily newsletter to receive timely earnings updates on FibroGen and other key companies, straight to your inbox. Sign Up View SMS TermsSMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. Skip Charts & View Estimated and Actual Earnings DataFGEN Earnings Estimates and Actuals by QuarterEarnings Estimates and Acutals by Quarter Chart DescriptionThe chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.FGEN Estimated and Actual Revenue by QuarterEstimated Revenue and Actual Revenue by Quarter Chart DescriptionThe chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter. FibroGen Analyst EPS EstimatesQuarterNumber of EstimatesLow EstimateHigh EstimateAverage EstimateQ1 20261-$4.29-$4.29-$4.29Q2 20261-$4.25-$4.25-$4.25Q3 20261-$4.44-$4.44-$4.44Q4 20261-$4.40-$4.40-$4.40 FibroGen Earnings History by Quarter Custom Range 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 5 Years 10 Years Time Frame Start Date End Date Export DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueDetails11/10/2025Q3 2025-$4.01-$1.61+$2.40$49.61$1.64M$1.08M8/11/2025Q2 2025-$2.25-$3.38 -$1.13-$1.88$2.88M$1.30M5/12/2025Q1 2025$0.75-$4.00 -$4.75$0.05$2.00M$2.70M3/17/2025Q4 2024-$2.00-$2.00-$0.18$24.91M$3.14M11/12/2024Q3 2024-$9.50-$4.25+$5.25-$0.17$34.00M$46.33M8/6/2024Q2 2024-$6.25-$4.00+$2.25-$0.16$33.00M$50.64M Data powered by Fiscal.ai. FibroGen Earnings - Frequently Asked Questions When did FibroGen announce their last quarterly earnings? FibroGen (NASDAQ:FGEN) last announced its quarterly earning data on Monday, November 10, 2025. Learn more on FGEN's earnings history. Did FibroGen beat their earnings estimates last quarter? In the previous quarter, FibroGen (NASDAQ:FGEN) reported ($1.61) earnings per share (EPS) to beat the analysts' consensus estimate of ($4.01) by $2.40. Learn more on analysts' earnings estimate vs. FGEN's actual earnings. How can I listen to FibroGen's earnings conference call? The conference call for FibroGen's latest earnings report can be listened to online. Listen to Conference Call How can I read FibroGen's conference call transcript? The conference call transcript for FibroGen's latest earnings report can be read online. Read Transcript How much revenue does FibroGen generate each year? FibroGen (NASDAQ:FGEN) has a recorded annual revenue of $29.62 million. How much profit does FibroGen generate each year? FibroGen (NASDAQ:FGEN) has a recorded net income of -$47.58 million. FGEN has generated $53.48 earnings per share over the last four quarters. What is FibroGen's price-to-earnings ratio? FibroGen (NASDAQ:FGEN) has a trailing price-to-earnings ratio of 0.18. What is FibroGen's EPS forecast for next year? FibroGen's earnings are expected to grow from ($0.80) per share to ($0.45) per share in the next year. More Earnings Resources from MarketBeat Related Companies ProQR Therapeutics Earnings Jyong Biotech Earnings Acumen Pharmaceuticals Earnings Molecular Partners Earnings Assertio Earnings Spero Therapeutics Earnings Organigram Global Earnings Black Diamond Therapeutics Earnings Connect Biopharma Earnings vTv Therapeutics Earnings Earnings Tools Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Latest Articles Was Decker’s Double Beat a Bullish Signal—Or Mere HOKA’s-Pocus?Workday Validates AI Flywheel: Stock Price Recovery BeginsOverextended, e.l.f. Beauty Is Primed to Rebound in Back HalfDeere Beats Q2 Estimates, But Ag Weakness Weighs on OutlookNVIDIA Price Pullback? Don’t Count on It, Business Is AcceleratingMeta Platforms 10% Layoff Raises a Bigger Question About AI SpendingBiogen Stock Slides After Trial Miss, But Analysts Stay Bullish This page (NASDAQ:FGEN) was last updated on 5/24/2026 by MarketBeat.com Staff. From Our PartnersHey, it's Jon Najarian. The SpaceX IPO is right around the corner. But I discovered Elon may have something BIGGER planned. Check this out before June 9th...After being invited to the SpaceX launch headquarters in Cape Canaveral from one of Elon's top lobbyists… Hall...Banyan Hill Publishing | SponsoredYour computer is about to become a museum pieceFuturist George Gilder - who predicted the smartphone years before the iPhone launched - believes today's AI d...Eagle Publishing | SponsoredGoldman Sachs just told you what to buy (most people missed it)Goldman Sachs just revealed that 40% of AI data centers will be crippled by electricity shortages by 2027 - no...Behind the Markets | SponsoredFrom the man who predicted 2008 crash…Porter Stansberry, founder of one of the largest financial research firms in the world, says he's breaking the...Porter & Company | SponsoredYour $29.97 book is free todayWhy Some Traders Skip Stocks Entirely You don't need a big account to trade options. In fact, options ca...Profits Run | SponsoredYou have until June 1Macroeconomic strategist Dr. Mark Skousen believes June 1 marks a critical turning point for one of the most o...The Oxford Club | SponsoredI was right about SpaceXJeff Brown predicted Bitcoin before it climbed as high as 52,400%, Tesla before 2,150%, and Nvidia before 32,0...Brownstone Research | SponsoredPH: Do THESE 4 things to your bank account now …In a few short months, the US government could gain unprecedented powers over personal bank accounts - includi...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding FibroGen, Inc Please log in to your account or sign up in order to add this asset to your watchlist. Share FibroGen With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
